What is the likely cause of coffee brown vomitus in an elderly patient with a history of ischemic stroke who recently restarted aspirin (acetylsalicylic acid) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Coffee Brown Vomitus in Elderly Patient on Aspirin After Ischemic Stroke

The coffee brown vomitus represents upper gastrointestinal bleeding, most likely from aspirin-induced gastric mucosal injury causing gastritis or peptic ulcer disease, which manifests as hematemesis with blood that has been partially digested by gastric acid. 1

Pathophysiology of Aspirin-Induced Upper GI Bleeding

  • Aspirin causes direct gastric mucosal damage through inhibition of cyclooxygenase (COX), reducing protective prostaglandin synthesis in the gastric mucosa, leading to erosions, ulcers, and bleeding. 1, 2

  • The principal toxicity of aspirin is gastrointestinal hemorrhage, with an annual risk of serious GI bleeding of approximately 0.4% in patients on low-dose aspirin (≤325 mg), which is 2.5 times the risk for nonusers. 1

  • Coffee-ground appearance occurs when hemoglobin in blood is converted to hematin by gastric acid, indicating the blood has been in the stomach long enough for this chemical transformation. 2

Risk Factors Present in This Patient

  • Advanced age (elderly) is a significant independent risk factor for aspirin-induced GI bleeding. 1, 2, 3

  • Recent restart of aspirin after stroke represents a critical period where the gastric mucosa may not have adapted to aspirin exposure. 2, 3

  • History of ischemic stroke itself is associated with increased GI bleeding risk, as cardiovascular and neurological disorders appear to enhance GI toxicity. 3

  • The dose-dependent nature of aspirin GI toxicity means even low-dose aspirin (75-325 mg) carries substantial bleeding risk, though higher doses increase this risk further. 1, 2

Immediate Clinical Management

  • Continue aspirin without interruption, as the mortality benefit from preventing recurrent stroke outweighs bleeding risk in this patient only 20 days post-ischemic stroke. 4

  • Initiate high-dose intravenous proton pump inhibitor immediately (80 mg IV bolus followed by 8 mg/hour infusion) to reduce gastric acid and promote hemostasis. 4

  • Perform urgent upper endoscopy within 12 hours while continuing aspirin to identify the bleeding source and achieve endoscopic hemostasis. 4

  • Resuscitate with intravenous fluids and transfuse packed red blood cells only if hemodynamic instability persists. 4

Long-Term Prevention Strategy

  • Prescribe a proton pump inhibitor indefinitely to all patients continuing aspirin after GI bleeding, as this substantially reduces risk of recurrent bleeding to near zero (0.7%). 1, 4, 2

  • Use pantoprazole or esomeprazole preferentially, as omeprazole may reduce effectiveness of other antiplatelet agents through CYP2C19 inhibition if dual therapy becomes necessary. 4

  • The combination of aspirin plus esomeprazole 20 mg twice daily is superior to switching to clopidogrel alone for preventing recurrent GI bleeding (0.7% vs 8.6% recurrence rate). 1

Critical Pitfalls to Avoid

  • Never discontinue aspirin abruptly in this patient, as withdrawal increases cardiovascular and recurrent stroke risk, which would be catastrophic at 20 days post-ischemic stroke. 4, 5

  • Do not switch from aspirin to clopidogrel as a bleeding prevention strategy, as clopidogrel alone actually increases bleeding risk (8.6%) compared to aspirin plus PPI (0.7%). 1, 5

  • Avoid adding NSAIDs or COX-2 inhibitors, as concomitant use dramatically increases GI bleeding risk. 1, 3

  • Do not use dual antiplatelet therapy (aspirin plus clopidogrel) long-term for stroke prevention alone, as it significantly increases bleeding risk without additional benefit beyond the acute period. 4

Additional Considerations

  • Test for and eradicate Helicobacter pylori if present, as this further reduces risk of upper GI bleeding in patients on chronic aspirin therapy. 2, 3

  • The first 90 days post-stroke carry the highest risk of recurrence, making aspirin continuation absolutely essential despite the bleeding episode. 4

  • Enteric-coated aspirin does not reduce GI bleeding risk despite common belief. 1, 3

  • Monitor hemoglobin at 1 week and 1 month post-discharge to detect occult recurrent bleeding. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Per Rectal Bleeding in Patients on Dual Antiplatelet Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hematuria in Patients on Antiplatelet Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.